HIV (human immunodeficiency virus), a virus that attacks the immune system, can lead to AIDS (acquired immunodeficiency syndrome) if left untreated. The first case of HIV being cured through a stem cell transplant occurred in 2009 when a Berlin man with HIV received stem cells from a donor with a mutated CCR5 gene, which normally codes for a receptor on white blood cell surfaces that HIV uses to infect new cells. The CCR5 mutation makes it difficult for the virus to infect cells, making this patient HIV resistant. Four more people have since been similarly cured.

This study was conducted on eight Mauritian cynomolgus macaques. All eight of the study's monkeys were infected with HIV. Four underwent a transplant with HIV-negative donor stem cells; the other four did not have transplants.

Two of the four monkeys that received transplants died, and two were cured of HIV after being treated for the graft-versus-host disease commonly associated with stem cell transplants. Both monkeys remain HIV-free today, four years after transplantation, reportedly the first time HIV-cured research animals have survived long term.

The scientists found that the animals overcame HIV in two ways. First, the transplanted donor stem cells helped kill the recipients' HIV-infected cells by recognizing them as foreign invaders and attacking them. Second, in the two animals that died, subsequent experiments verified that HIV infected the transplanted donor cells while they were attacking the HIV. The researchers determined that stopping HIV from using the CCR5 receptor to infect donor cells is necessary for a cure to occur.

The researchers also discovered that HIV was cleared from the animals' bodies in a series of steps, beginning with the blood circulating in the monkeys' arms and legs. Next, HIV became undetectable in lymph nodes in the limbs, followed by lymph nodes in the abdomen.

The serial process of HIV clearance could help physicians evaluate potential cures and may help explain why HIV later returned in some stem cell transplant patients who initially appeared to be cured. The researchers hypothesize that those patients may have had a small reservoir of HIV in their abdominal lymph nodes that enabled the virus to persist and re-spread. They continue to study the two surviving animals, seeking to identify the specific immune cells involved.

"Five patients have already demonstrated that HIV can be cured," lead researcher Jonah Sacha, Oregon Health & Science University professor, said in a statement. "We hope our discoveries will help to make this cure work for anyone -- ideally through a single injection instead of a stem cell transplant. This study is helping us home in on the mechanisms involved in making that cure happen."

Strategic self-limiting production of infectious HIV particles by CRISPR
Temple University researchers found that genetic alterations that give rise to a rare congenital disorder known as MOGS-CDG paradoxically also prevent...

Discovery of severe form of mpox spurs call for update to list of AIDS-defining diseases
Researchers have identified a new, severe form of mpox that has a 15% mortality rate in people with advanced HIV disease and immunosuppression.

Researchers study how latent HIV evades antiretrovirals and immunity
Duke University researchers have discovered that an immune response meant to help fight infections is the likely mechanism that drives human immunodeficiency...

New insights on how HIV-1 evades the immune system
Université de Montréal researchers found that the type of virus used as a model significantly impacted the efficacy of non-neutralizing antibodies against...

Cow mucus-derived lubricant stops HIV, herpes in lab tests
A synthetic prophylactic gel based on cow mucus is 70% effective against HIV and 80% effective against herpes in lab tests, a new study reveals.

AIDS 2022 research sheds new light on HIV cells
New research presented at the AIDS 2022 conference shows the HIV-infected memory CD4+ T-cell reservoir is a distinctive cell population that may be uniquely...

Computational approach predicts effectiveness of bNAb combinations to treat HIV
Researchers have developed a computational approach to predict the effectiveness of broadly neutralizing antibodies (bNAbs) combinations to treat HIV...